{
  "id": 15555623,
  "title": "Up 10% in October: an AI-picked stock defied Asia’s $2 trillion chip rout",
  "url": "https://urgent.news/2026/10/19/up-10-in-october-an-ai-picked-stock-defied-asias-2-trillion-chip-rout",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-19T03:20:23.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/up-10-in-october-an-aipicked-stock-defied-asias-2-trillion-chip-rout-4956262"
  },
  "original_language": "en",
  "account": "In October, an AI-powered stock selection defied Asia's $2 trillion chip sector rout. The Nikkei and Kospi saw declines of 2% and 1.6% respectively, driven by profit-taking in SK Hynix and Samsung, and concerns that AI spending outpaced actual revenue. However, defensive and cash-generative healthcare stocks emerged as strong performers. The Healthcare Heroes strategy, which screens the S&P 500 health-care sector monthly, saw a 22.10% gain since its August 15, 2025 launch, outperforming the sector benchmark by 7.3 percentage points. AbbVie topped the list with a 10.5% gain this month, trading at $285.42, just 2.1% below its 52-week high. The strategy's other holdings also gained, with an equal-weighted average increase of over 6%. Other Strategies, Small-Cap Sprinters and Dominate the Dow, also rode the rotation, with the former up 29.68% and the latter 18.29% since the start of 2026. This stands in stark contrast to the chip sector, where companies like Intel, Applied Materials, Lam Research, and Onto Innovation suffered double-digit declines. The AI-powered system evaluates thousands of equities each month, using over 15 years of financial data and 150 quantitative models to identify high-conviction stocks with medium-term upside potential.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}